152 related articles for article (PubMed ID: 12610070)
1. A new case of lipoatrophy with lispro insulin in insulin pump therapy: is there any insulin preparation free of complications?
Ampudia-Blasco FJ; Hasbum B; Carmena R
Diabetes Care; 2003 Mar; 26(3):953-4. PubMed ID: 12610070
[No Abstract] [Full Text] [Related]
2. Lipoatrophy associated with lispro insulin in insulin pump therapy: an old complication, a new cause?
Griffin ME; Feder A; Tamborlane WV
Diabetes Care; 2001 Jan; 24(1):174. PubMed ID: 11194227
[No Abstract] [Full Text] [Related]
3. Vitiligo associated with subcutaneous insulin lispro infusion in type 1 diabetes.
Burge MR; Carey JD
Diabetes Care; 2004 Jan; 27(1):275-6. PubMed ID: 14694005
[No Abstract] [Full Text] [Related]
4. A case of lipoatrophy with Lispro insulin without insulin pump therapy.
Arranz A; Andia V; López-Guzmán A
Diabetes Care; 2004 Feb; 27(2):625-6. PubMed ID: 14747261
[No Abstract] [Full Text] [Related]
5. Lipoatrophy induced by recombinant human insulin injection.
Murao S; Hirata K; Ishida T; Takahara J
Intern Med; 1998 Dec; 37(12):1031-3. PubMed ID: 9932635
[TBL] [Abstract][Full Text] [Related]
6. Metabolic decompensation in pump users due to lispro insulin precipitation.
Wolpert HA; Faradji RN; Bonner-Weir S; Lipes MA
BMJ; 2002 May; 324(7348):1253. PubMed ID: 12028980
[No Abstract] [Full Text] [Related]
7. "Lipoblastoma-like" lipoatrophy induced by human insulin: morphological evidence for local dedifferentiation of adipocytes?
Jermendy G; Nádas J; Sápi Z
Diabetologia; 2000 Jul; 43(7):955-6. PubMed ID: 10952472
[No Abstract] [Full Text] [Related]
8. Lipodystrophy reactions to insulin: effects of continuous insulin infusion and new insulin analogs.
Radermecker RP; Piérard GE; Scheen AJ
Am J Clin Dermatol; 2007; 8(1):21-8. PubMed ID: 17298103
[TBL] [Abstract][Full Text] [Related]
9. A case of lipoatrophy with insulin detemir.
Del Olmo MI; Campos V; Abellán P; Merino-Torres JF; Piñón F
Diabetes Res Clin Pract; 2008 Apr; 80(1):e20-1. PubMed ID: 18281121
[TBL] [Abstract][Full Text] [Related]
10. Lipoatrophy associated with rapid-acting insulin analogues in young patients with type 1 diabetes mellitus.
Szypowska A; Skórka A; Pańkowska E
Pediatr Endocrinol Diabetes Metab; 2008; 14(2):117-8. PubMed ID: 18721499
[TBL] [Abstract][Full Text] [Related]
11. [Human insulin-induced lipoatrophy].
Jermendy G; Nádas J; Sápi Z
Orv Hetil; 2000 Oct; 141(44):2393-6. PubMed ID: 11105557
[TBL] [Abstract][Full Text] [Related]
12. Images in clinical medicine. Injection-site lipoatrophy.
Sackey AH
N Engl J Med; 2009 Nov; 361(19):e41. PubMed ID: 19890122
[No Abstract] [Full Text] [Related]
13. Resolution of lipohypertrophy following change of short-acting insulin to insulin lispro (Humalog).
Roper NA; Bilous RW
Diabet Med; 1998 Dec; 15(12):1063-4. PubMed ID: 9868982
[TBL] [Abstract][Full Text] [Related]
14. Nonmetabolic complications of continuous subcutaneous insulin infusion: a patient survey.
Pickup JC; Yemane N; Brackenridge A; Pender S
Diabetes Technol Ther; 2014 Mar; 16(3):145-9. PubMed ID: 24180294
[TBL] [Abstract][Full Text] [Related]
15. Glargine and lispro: two cases of mistaken identity.
Adlersberg MA; Fernando S; Spollett GR; Inzucchi SE
Diabetes Care; 2002 Feb; 25(2):404-5. PubMed ID: 11815523
[No Abstract] [Full Text] [Related]
16. Severe Hypoglycemia Before Landing in a Patient with Type 1 Diabetes Using Sensor-Augmented Pump Therapy.
Viñals C; Pané A; Quirós C; Giménez M; Conget I
Diabetes Technol Ther; 2017 Aug; 19(8):491-492. PubMed ID: 28594566
[No Abstract] [Full Text] [Related]
17. [Insulin-induced lipoatrophy in children].
Niinikoski H; Näntö-Salonen K; Ruusu P; Kinnala A; Putto-Laurila A; Toppari J; Keskinen P
Duodecim; 2010; 126(11):1328-32. PubMed ID: 20681357
[TBL] [Abstract][Full Text] [Related]
18. Severe lipoatrophy with human insulin: successfully treated by CSII.
Chantelau E; Reuter M; Schotes S; Starke AA
Diabet Med; 1993 Jul; 10(6):580-1. PubMed ID: 8365099
[No Abstract] [Full Text] [Related]
19. Cessation of insulin infusion at night-time during CSII-therapy: comparison of regular human insulin and insulin lispro.
Reichel A; Rietzsch H; Köhler HJ; Pfützner A; Gudat U; Schulze J
Exp Clin Endocrinol Diabetes; 1998; 106(3):168-72. PubMed ID: 9710355
[TBL] [Abstract][Full Text] [Related]
20. Successful treatment with insulin analog lispro in IDDM with delayed absorption of subcutaneously applied human regular insulin and complicated intraperitoneal insulin infusion. A case report.
Meier M; Brand J; Standl E; Schnell O
Diabetes Care; 1998 Jul; 21(7):1044-5. PubMed ID: 9653592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
